Economic data suggest hepatitis B vaccination is generally justified in neonates and high-risk adults New Drugs and Therapeutics 09 November 2012 Pages: 1 - 4
Epalrestat: place in therapy of diabetic complications not established New Drugs and Therapeutics 09 November 2012 Pages: 6 - 8
Zileuton: a potential first-line drug for asthma prophylaxis New Drugs and Therapeutics 09 November 2012 Pages: 8 - 8
Negative symptoms of schizophrenia remain a diagnostic and therapeutic challenge New Drugs and Therapeutics 09 November 2012 Pages: 8 - 10
Salient points regarding potassium homeostasis in cardiovascular disease New Drugs and Therapeutics 09 November 2012 Pages: 11 - 12
Interpret differential NSAID tolerability data cautiously Drug Reactions and Interactions 09 November 2012 Pages: 12 - 14
Economic and clinical benefits closely related in prevention of DVT after hip surgery Drug Economics and Quality of Life 09 November 2012 Pages: 14 - 16
